Immuno-Oncology

Global Market Trajectory & Analytics

MCP12538

EXECUTIVE ENGAGEMENTS

OUTREACH

7883
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1104
Interactions with Platform & by Email

PARTICIPANTS

236
Unique # Participated

VALIDATIONS

106
Responses Validated*

COMPETITORS

47
Responses Validated*

BRANDS

0
Responses Validated*
* Login for a full stack data experience

DATE

JUL 2020

TABLES

80

PAGES

157

EDITION

9

PRICE

USD $4950


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Immuno-Oncology estimated at US$63.9 Billion in the year 2020, is projected to reach a revised size of US$163.1 Billion by 2027, growing at a CAGR of 14.3% over the analysis period 2020-2027. Immune Checkpoint Inhibitors, one of the segments analyzed in the report, is projected to record a 14.2% CAGR and reach US$143.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immune System Modulators segment is readjusted to a revised 15% CAGR for the next 7-year period.
The Immuno-Oncology market in the U.S. is estimated at US$18.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$28.4 Billion by the year 2027 trailing a CAGR of 13.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.7% and 12.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.
In the global Cancer Vaccines segment, USA, Canada, Japan, China and Europe will drive the 15.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$19.5 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 157-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

SELECT PLAYERS

AbbVie, Inc.; Aduro BioTech, Inc.; Amgen, Inc.; AstraZeneca PLC; Bavarian Nordic A/S; Bristol-Myers Squibb Company; Celgene Corporation; Celldex Therapeutics, Inc.; Eli Lilly and Company; EMD Serono, Inc.; F. Hoffmann-La Roche AG; Galena Biopharma, Inc.; Gilead Sciences, Inc.; ImmunoCellular Therapeutics Ltd.; Incyte Corporation; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.; Prometheus Laboratories, Inc.; Sanofi SA

SEGMENTS

» Cancer Type (Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Cancer Types) » Therapy Type (Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Oncolytic Virus, Other Therapy Types)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Global Competitor Market Shares
Immuno-Oncology Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Immuno-Oncology Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
Immuno-Oncology Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
Immune Checkpoint Inhibitors (Therapy Type) World Market by Region/Country in US$ Million: 2020 to 2027
Immune Checkpoint Inhibitors (Therapy Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
Immune System Modulators (Therapy Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
Immune System Modulators (Therapy Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
Cancer Vaccines (Therapy Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
Cancer Vaccines (Therapy Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
Oncolytic Virus (Therapy Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
Oncolytic Virus (Therapy Type) Market Share Breakdown by Region/Country: 2020 VS 2027
Other Therapy Types (Therapy Type) World Market by Region/Country in US$ Million: 2020 to 2027
Other Therapy Types (Therapy Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
Melanoma (Cancer Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
Melanoma (Cancer Type) Market Percentage Share Distribution by Region/Country: 2020 VS 2027
Lung Cancer (Cancer Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
Lung Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
Blood Cancer (Cancer Type) World Market by Region/Country in US$ Million: 2020 to 2027
Blood Cancer (Cancer Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
Renal Cell Carcinoma (Cancer Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
Renal Cell Carcinoma (Cancer Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
Bladder Cancer (Cancer Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
Bladder Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
Other Cancer Types (Cancer Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
Other Cancer Types (Cancer Type) Market Share Breakdown by Region/Country: 2020 VS 2027
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Immuno-Oncology Market Share (in %) by Company: 2019 & 2025
United States Immuno-Oncology Market Estimates and Projections in US$ Million by Therapy Type: 2020 to 2027
United States Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027
United States Immuno-Oncology Market Estimates and Projections in US$ Million by Cancer Type: 2020 to 2027
United States Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027
CANADA
Canadian Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020 to 2027
Immuno-Oncology Market in Canada: Percentage Share Breakdown of Sales by Therapy Type for 2020 and 2027
Canadian Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020 to 2027
Immuno-Oncology Market in Canada: Percentage Share Breakdown of Sales by Cancer Type for 2020 and 2027
JAPAN
Japanese Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Therapy Type for the Period 2020-2027
Japanese Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027
Japanese Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2020-2027
Japanese Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027
CHINA
Chinese Immuno-Oncology Market Growth Prospects in US$ Million by Therapy Type for the Period 2020-2027
Chinese Immuno-Oncology Market by Therapy Type: Percentage Breakdown of Sales for 2020 and 2027
Chinese Immuno-Oncology Market Growth Prospects in US$ Million by Cancer Type for the Period 2020-2027
Chinese Immuno-Oncology Market by Cancer Type: Percentage Breakdown of Sales for 2020 and 2027
EUROPE
Market Facts & Figures
European Immuno-Oncology Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Immuno-Oncology Market Demand Scenario in US$ Million by Region/Country: 2018-2025
European Immuno-Oncology Market Share Shift by Region/Country: 2020 VS 2027
European Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020-2027
European Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027
European Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020-2027
European Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027
FRANCE
Immuno-Oncology Market in France by Therapy Type: Estimates and Projections in US$ Million for the Period 2020-2027
French Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027
Immuno-Oncology Market in France by Cancer Type: Estimates and Projections in US$ Million for the Period 2020-2027
French Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027
GERMANY
Immuno-Oncology Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy Type for the Period 2020-2027
German Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027
Immuno-Oncology Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2020-2027
German Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027
ITALY
Italian Immuno-Oncology Market Growth Prospects in US$ Million by Therapy Type for the Period 2020-2027
Italian Immuno-Oncology Market by Therapy Type: Percentage Breakdown of Sales for 2020 and 2027
Italian Immuno-Oncology Market Growth Prospects in US$ Million by Cancer Type for the Period 2020-2027
Italian Immuno-Oncology Market by Cancer Type: Percentage Breakdown of Sales for 2020 and 2027
UNITED KINGDOM
United Kingdom Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Therapy Type for the Period 2020-2027
United Kingdom Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027
United Kingdom Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2020-2027
United Kingdom Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027
REST OF EUROPE
Rest of Europe Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020-2027
Rest of Europe Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027
Rest of Europe Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020-2027
Rest of Europe Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027
ASIA-PACIFIC
Immuno-Oncology Market in Asia-Pacific by Therapy Type: Estimates and Projections in US$ Million for the Period 2020-2027
Asia-Pacific Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027
Immuno-Oncology Market in Asia-Pacific by Cancer Type: Estimates and Projections in US$ Million for the Period 2020-2027
Asia-Pacific Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027
REST OF WORLD
Rest of World Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020 to 2027
Immuno-Oncology Market in Rest of World: Percentage Share Breakdown of Sales by Therapy Type for 2020 and 2027
Rest of World Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020 to 2027
Immuno-Oncology Market in Rest of World: Percentage Share Breakdown of Sales by Cancer Type for 2020 and 2027
Total Companies Profiled: 47

General queries: Info411@StrategyR.com